When enrollment is open, eligible patients, are enrolled after in-formed consent and will have biannual visits. Each visit will include an interview, a short physical exam, a gyn exam with pap smear, and laboratory specimen collection. To read more about the important studies and findings conducted by the WIHS cohort, review this list of recent studies.
HOW TO JOIN THIS STUDY
This study is currently closed to enrollment. Our site has enrolled 115 women in Alabama and 115 women in Mississippi who are culturally and ethnically diversity women that have HIV or at risk for HIV This study is an observational study that does not provide medication or any other intervention treatment to our participants. If you choose to enroll in this study, you will be asked to provide data through
- Comprehensive Interviews
- Physical and gynecological medical examinations
- And collection of specimens that include blood, urine, hair, and cervical fluids.
If you have questions or would like to contact a WIHS staff person, please contact Zenoria Causey at UAB, 205-975-9128 and Venetra McKinney at UMMC at 601-815-51878
- Women must be between ages 25-60 for both HIV-positive and HIV-negative recruits.
- Willing to come every 6 months for clinic visit
- Willing to have blood drawn, pelvic exam and answer study question
HIV negative (-)The enrollment criteria that must be met by HIV-negative women are at least one of which must have been met in the five years prior to enrollment, are as follows:
- Reported injection drug use, or use of crack, cocaine, heroin, or methamphetamine
- Diagnosis by a health care provider with an STD
- Reported having unprotected sex with three or more men
- Reported having sex for drugs, money, or shelter
- Reported having sex with six or more men
- Reported having sex with known HIV-positive man
- Partner reported injection drug use, or use of crack, cocaine, heroin, or methamphetamine
- Partner diagnosed by a health care provider with an STD
- Partner reported having unprotected sex with three or more women or men
- Partner reported having sex for drugs, money, or shelter
- Partner reported having sex with six or more women or men
- Partner reported having sex with known HIV-positive woman or man
HIV positive (+)
- HAART users must have started their first HAART regimen subsequent to December 31, 2004, unless the HAART use was during pregnancy or for PEP/PrEP only.
- Women must not have ever used ddI (Videx, didanosine), ddC (Hivid, zalcitabine) or d4T (Zerit, stavudine) unless use was only during pregnancy or for PEP/PrEP.
- Women may not be on non-HAART ART at time of enrollment and must not have used ART before starting HAART, unless use was only during pregnancy or for PEP/PrEP.
- Women must be biologically female at birth.
We are presently forming The WIHS National Community Advisory Board (NCAB) which will represent the participants in the Women's Interagency HIV Study (WIHS). The Mission Statement of the NCAB is to:
- Provide on-going community, science, psycho-social and political input to the national WIHS agenda.
- Help design mechanism to assure that 100% of WIHS participants are representative for the community at large and to inform, educate and support these participants over time.
- Help design mechanisms to assure access of HIV infected/affected women to WIHS research sites and retention of these participants over time.
- Advocate for adequate research funding, to allow the full WIHS research agenda to be fulfilled.
- Provide support for the site and/or local community advisory boards and encourage involvement at the local level.
- Facilitate translation of WIHS related information to the community.Represent and be accessible to community members for WIHS related concerns.
The women of WIHS will be asked to maintain an ongoing representation of the thoughts and cares of the women who are affected by HIV and those who are at risk. The WIHS NCAB will be asked to meet regularly to discuss topics, discuss matters and have a little fun fellowship. Also a voted upon individual and an alternate will be asked to participant in representing our sites during national WIHS functions. As we go forward to advancing the HIV research field, we must ensure that the women of WIHS are properly hear and represented. We are asking if anyone is interested in being part of WIHS/NCAB please contact Zenoria Causey at email@example.com.